Global Gadoterate Meglumine Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
1.8845Gm/5Ml
3.769Gm/10Ml
5.6535Gm/15Ml
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Guerbet Group
GE
Bayer
Sanochemia
T2Pharma
b.e.imaging GmbH
Hengrui Medicine
Table of Content
1 Gadoterate Meglumine Market Overview
1.1 Product Overview and Scope of Gadoterate Meglumine
1.2 Gadoterate Meglumine Segment by Type
1.2.1 Global Gadoterate Meglumine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1.8845Gm/5Ml
1.2.3 3.769Gm/10Ml
1.2.4 5.6535Gm/15Ml
1.2.5 Others
1.3 Gadoterate Meglumine Segment by Application
1.3.1 Global Gadoterate Meglumine Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Gadoterate Meglumine Market Size Estimates and Forecasts
1.4.1 Global Gadoterate Meglumine Revenue 2016-2027
1.4.2 Global Gadoterate Meglumine Sales 2016-2027
1.4.3 Gadoterate Meglumine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Gadoterate Meglumine Market Competition by Manufacturers
2.1 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gadoterate Meglumine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gadoterate Meglumine Manufacturing Sites, Area Served, Product Type
2.5 Gadoterate Meglumine Market Competitive Situation and Trends
2.5.1 Gadoterate Meglumine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gadoterate Meglumine Players Market Share by Revenue
2.5.3 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gadoterate Meglumine Retrospective Market Scenario by Region
3.1 Global Gadoterate Meglumine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gadoterate Meglumine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gadoterate Meglumine Market Facts & Figures by Country
3.3.1 North America Gadoterate Meglumine Sales by Country
3.3.2 North America Gadoterate Meglumine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Gadoterate Meglumine Market Facts & Figures by Country
3.4.1 Europe Gadoterate Meglumine Sales by Country
3.4.2 Europe Gadoterate Meglumine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gadoterate Meglumine Market Facts & Figures by Region
3.5.1 Asia Pacific Gadoterate Meglumine Sales by Region
3.5.2 Asia Pacific Gadoterate Meglumine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Gadoterate Meglumine Market Facts & Figures by Country
3.6.1 Latin America Gadoterate Meglumine Sales by Country
3.6.2 Latin America Gadoterate Meglumine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gadoterate Meglumine Market Facts & Figures by Country
3.7.1 Middle East and Africa Gadoterate Meglumine Sales by Country
3.7.2 Middle East and Africa Gadoterate Meglumine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gadoterate Meglumine Historic Market Analysis by Type
4.1 Global Gadoterate Meglumine Sales Market Share by Type (2016-2021)
4.2 Global Gadoterate Meglumine Revenue Market Share by Type (2016-2021)
4.3 Global Gadoterate Meglumine Price by Type (2016-2021)
5 Global Gadoterate Meglumine Historic Market Analysis by Application
5.1 Global Gadoterate Meglumine Sales Market Share by Application (2016-2021)
5.2 Global Gadoterate Meglumine Revenue Market Share by Application (2016-2021)
5.3 Global Gadoterate Meglumine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Guerbet Group
6.1.1 Guerbet Group Corporation Information
6.1.2 Guerbet Group Description and Business Overview
6.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Guerbet Group Gadoterate Meglumine Product Portfolio
6.1.5 Guerbet Group Recent Developments/Updates
6.2 GE
6.2.1 GE Corporation Information
6.2.2 GE Description and Business Overview
6.2.3 GE Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GE Gadoterate Meglumine Product Portfolio
6.2.5 GE Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bayer Gadoterate Meglumine Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Sanochemia
6.4.1 Sanochemia Corporation Information
6.4.2 Sanochemia Description and Business Overview
6.4.3 Sanochemia Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanochemia Gadoterate Meglumine Product Portfolio
6.4.5 Sanochemia Recent Developments/Updates
6.5 T2Pharma
6.5.1 T2Pharma Corporation Information
6.5.2 T2Pharma Description and Business Overview
6.5.3 T2Pharma Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 T2Pharma Gadoterate Meglumine Product Portfolio
6.5.5 T2Pharma Recent Developments/Updates
6.6 b.e.imaging GmbH
6.6.1 b.e.imaging GmbH Corporation Information
6.6.2 b.e.imaging GmbH Description and Business Overview
6.6.3 b.e.imaging GmbH Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 b.e.imaging GmbH Gadoterate Meglumine Product Portfolio
6.6.5 b.e.imaging GmbH Recent Developments/Updates
6.7 Hengrui Medicine
6.6.1 Hengrui Medicine Corporation Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates
7 Gadoterate Meglumine Manufacturing Cost Analysis
7.1 Gadoterate Meglumine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gadoterate Meglumine
7.4 Gadoterate Meglumine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gadoterate Meglumine Distributors List
8.3 Gadoterate Meglumine Customers
9 Gadoterate Meglumine Market Dynamics
9.1 Gadoterate Meglumine Industry Trends
9.2 Gadoterate Meglumine Growth Drivers
9.3 Gadoterate Meglumine Market Challenges
9.4 Gadoterate Meglumine Market Restraints
10 Global Market Forecast
10.1 Gadoterate Meglumine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gadoterate Meglumine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gadoterate Meglumine by Type (2022-2027)
10.2 Gadoterate Meglumine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gadoterate Meglumine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gadoterate Meglumine by Application (2022-2027)
10.3 Gadoterate Meglumine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gadoterate Meglumine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gadoterate Meglumine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer